Sleep Tests

Screening for Sleep Disordered Breathing

Compared with the Berlin Questionnaire and Epworth Sleepiness Scale, the STOP-Bang Questionnaire is a more accurate tool for detecting mild, moderate, and severe OSA​

  • Epworth Sleepiness Scale (ESS)

    • Validated 8-item questionnaire​ that measures subjective sleepiness

    • Is a simple and reliable method for measuring persistent daytime sleepiness in adults

    • Subjects are asked to rate how likely they will fall asleep in different situations

    • < 11 means low risk for sleepiness

    • ≥ 11 means high risk of sleepiness

    • There is considerable inter-individual variation in susceptibility to sleepiness resulting from OSA, some patients with AHI > 30 do not report increased ESS

  • Stanford Sleepiness Scale (SSS):

    • Measures feelings of sleepiness or tiredness at a particular time, but not sleep propensity

  • 4-Variable screening 

    • Gender (M, F)

    • BP

    • Snoring​

  • STOP

    • Snoring

    • ​Tiredness

    • Observed apnoeas

    • BP

  • STOP-Bang (2 or fewer “yes” answers, indicative of low risk for OSA; for 3 to 4 “yes” answers, indicative of moderate risk for OSA; for more than 5 “yes” answers, suggestive high risk for OSA)

    • Markers for STOP questionnaire, and

    • BMI (> 35 kg/m2)

    • Age (> 50 years)

    • Neck circumference (> 40 cm or 17 inches)

    • Gender​

    • Compared with the BQ, STOP, and ESS, the SBQ is a more accurate tool for detecting mild, moderate, and severe OSA

  • Age, sex difference, body mass index and the presence of comorbid conditions in participants are found to be substantial factors affecting the accuracy of screening tools, which should be considered when applying these questionnaires

Multiple Sleep Latency Test (MSLT)

What is it? Checks of excessive daytime sleepiness - measure TENDENCY to fall asleep in quiet environment 

Indications: ​

  • Narcolepsy 

    • To confirm diagnosis

    • To determine severity of sleepiness​

    • Before commencing treatment

  • OSA 

    • Mild to moderate OSA syndrome who complain of moderate to severe sleepiness​

  • Other causes of excessive sleep 

    • Idiopathic hypersomnia

    • Periodic limb movement disorder

    • Excessive cause of sleepiness unknown​

  • Circadian rhythm sleep disorders

    • ​May be useful but adequate scientific validation is not yet available

  • Assessment of treatment effects

    • Assess treatment response

    • Confirmation of sleepiness required for occupational safety

Indications for repeat MLST:

  • Initial test believed to be an invalid representation of the patient's status

  • When ambiguous or uninterpretable MSLT findings occur

  • When the response to treatment needs to be ascertained

  • When more than one sleep disorder is suspected​

Method: ​

  • Must be performed following all night PSG 

  • 5 nap opportunity to determine both severity of sleepiness and presence of 2 or more REM periods for the diagnosis of narcolepsy

  • People with idiopathic hypersomnia fall asleep easily but do not reach REM sleep during the nap trial. Other patients may fall asleep easily, such as those with sleep apnea and insufficient sleep

  • The clinical MSLT assesses sleep latency by the initial appearance of any sleep stage, including stage 1 sleep

  • During each nap trial, you will lie quietly in bed and try to go to sleep. Once the lights go off, the test will measure how long it takes for you to fall asleep. You will be awakened 15 minutes after you fall asleep. If you do not fall asleep within 20 minutes, the nap trial will end.​

  • A shorter 4-nap test may be performed for determination of excessive sleepiness, but this test is not reliable for the diagnosis of narcolepsy unless at least two sleep onset REM periods (SOREMPs) have occurred​

  • Sleep latency is defined as the elapsed time from lights-out to the first epoch of any sleep stage

There are no validated computerized analysis systems for the MSLT

Scoring and interpretation:​

  1. The MSLT technical report should include the onset and offset time of each nap, latency from lights out to the first epoch of sleep, amount of each sleep stage, total sleep time, mean latencies to sleep of all naps and number of sleep onset REM periods

  2. Sleep onset is determined by the first epoch of any stage of sleep, including stage 1 sleep

  3. The absence of sleep on any nap opportunity is recorded as a sleep latency of 20 minutes. This latency is included in the overall analysis of mean sleep latency

Reduced multiple sleep latency is seen in:

  • Sleep loss

  • Following use of sedating medications

  • During wakefulness in the late night or early morning hours

  • Among patients with sleep disorders associated with excessive sleepiness such as narcolepsy or OSA

MSL on both the MSLT and MWT does not discriminate well between patients with sleep disorders and normal populations

Maintenance of Wakefulness Test (MWT)​

  • Measures how alert someone is during the day ​and able to stay awake during a defined period of time and non-activity

  • Is a variation of the MLST but patient is instructed to STAY AWAKE

  • Is used less commonly than the MSLT and mainly used to assess improved alertness following therapeutic interventions

  • Is used in association with the clinical history to assess the ability to maintain wakefulness

Indications: ​assess severity of narcolepsy, OSA 

Method:

  • Given within 1.5-3 hours after waking

  • Full day test

  • 40 min test periods with breaks​​​​

Recorded items:​

  • Start time​

  • End time​

  • Total sleep time​

  • Time it took to fall asleep (sleep latency)​

Pulse Oximetry

  • Oximetry recordings can provide useful information in the assessment and management of children with known or suspected OSA

    • Oximetry cannot rule out significant OSA

    • Oximetry cannot differentiate obstructive from central respiratory events

  • Pulse oximeters measure SaO2 that is physiologically related to arterial oxygen tension (PaO2). Oximetry is thus relatively insensitive in detecting hypoxaemia in patients with high baseline PaO2

  • Are used in conjunction with respiratory rate to detect hypoxemia

  • Appropriate choice of device, settings, software and report format are critical to interpretation

  • Different probes have different accuracy

    • Finger probes having the lowest precision (ear probes better)

    • Accuracy deteriorates when SaO2 falls < 80% or in ventilator-dependent patients

    • When carboxylhaemoglobin (COHb) and Methemoglobin (MetHb) are present, the two wavelengths of light may not be able to differentiate

    • Anaemia does not affect pulse oximetry but sickle cell anaemia can cause inaccuracies

    • Hyperbilirubinaemia does not affect pulse oximetry

    • IV Dyes, nail polish (blue/ black/ green), fluorescent or xenon light can result in inaccurate and falsely low SpO2 readings

    • Acrylic nails do not interfere with pulse oximetry

    • Motion artifacts are a source of error and false alarms

    • Inaccurate oximetry readings have been observed in pigmented patients

    • Low perfusion states such as low cardiac output and hypothermia may impair peripheral perfusion making it difficult for a sensor to distinguish true signals from noise

Nocturnal pulse oximetry as a testing modality for pediatric OSA:

  • For a child suspected of having OSA, an abnormal nocturnal oximetry tracing has at least a 97% positive predictive value

  • Oximetry could:

    1. Be the definitive diagnostic test for straightforward OSA due to adenotonsillar hypertrophy

    2. Quickly and inexpensively identify children with a history suggesting sleep disordered breathing who would require PSG to elucidate the type and severity of SDB